Tata India Pharma & Healthcare Fund - IDCW - Direct Plan

Other Plans and Options
  • (-1.42%)Nav, as on 22-09-2023

  • Previous Nav

  • Net Change on 22-09-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option -1.93 11.88 22.80 15.25 17.53 10.98
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY PHARMA - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 22.80 15.25 17.53 0.93 658.94
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 25.71 15.96 16.89 1.01 5,544.92
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 26.39 15.36 18.65 1.15 3,174.41
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 28.34 17.67 17.45 1.03 2,032.95
Mirae Asset Healthcare Fund Direct IDCW Jul 02, 2018 19.86 15.70 20.34 0.58 1,812.41
UTI Healthcare Fund - Direct Plan - IDCW Jan 01, 2013 24.04 13.55 15.68 1.39 776.06

Fund Holdings as on 31-August-2023

  • SUN PHARMACEUTICAL INDUSTRIES LTD

  • LUPIN LTD

  • DR REDDYs LABORATORIES LTD

  • CIPLA LTD

  • AUROBINDO PHARMA LTD

  • DIVI LABORATORIES LTD

  • ALKEM LABORATORIES LTD

  • FORTIS HEALTHCARE LTD

  • ZYDUS LIFESCIENCES LTD

  • APOLLO HOSPITALS ENTERPRISE LTD

  • HEALTHCARE GLOBAL ENTERPRISES LTD

  • CASH / NET CURRENT ASSET

  • FDC LTD

  • AJANTA PHARMA LTD

  • SANOFI INDIA LTD

  • TORRENT PHARMACEUTICALS LTD

  • IPCA LABORATORIES LTD

  • ASTER DM HEALTHCARE LTD

  • MEDPLUS HEALTH SERVICES LTD

  • INDOCO REMEDIES LTD

  • SYNGENE INTERNATIONAL LTD

  • PROCTER & GAMBLE HEALTH LTD

  • MANKIND PHARMA LTD

  • AMI ORGANICS LTD

  • PI INDUSTRIES LTD

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD

  • A) REPO

  • PIRAMAL PHARMA LTD

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Pesticides & Agrochemicals

View More

  • Cash

  • Equity

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹658.94 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended down ₹-0.32(-1.42%)yesterday to ₹22.3971.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD, and

The Tata India Pharma & Healthcare Fund is managed by Meeta Shetty .

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

+91 (22) 66578282
kiran@tataamc.com
+91 (22) 22613782